Hyperthermic intraperitoneal chemotherapy stopped.

Peritoneal hyperthermia chemotherapy has not been stopped.

Peritoneal hyperthermia chemotherapy is one of the effective methods to treat malignant tumors. For some abdominal malignant tumors, such as gastric cancer, colorectal cancer and other patients with peritoneal metastasis, intraperitoneal hyperthermia chemotherapy can directly act on tumor lesions, increase local drug concentration, better kill cancer cells, effectively control the disease progression and improve the quality of life of patients.

Intraperitoneal hyperthermic chemotherapy usually requires close collaboration between a multidisciplinary team of surgeons, oncologists, anesthesiologists, etc. to ensure the safety and effectiveness of the treatment. Careful manipulation and coordination of each step is critical to the success of the treatment.

With the progress of medical technology, the equipment and technology of intraperitoneal hyperthermia chemotherapy are constantly improved and optimized to make it safer, more effective and convenient, and bring more benefits to patients. Peritoneal hyperthermia

chemotherapy has a unique status and value in the treatment of malignant tumors. It should not be misunderstood or viewed one-sidedly, but should be reasonably applied to suitable patients and play an active role in the treatment and rehabilitation of patients.